NEW YORK (TheStreet) -- Vitamin Shoppe (VSI) shares are down 7.82% to $39 in trading on Wednesday after the vitamin and supplement retailer missed analysts' first quarter forecasts and cut its own full year financial guidance before the opening bell today.
The North Berge, NJ-based company reported first quarter earnings of 63 cents per share, falling short of analysts 74 cent per share earnings expectations by 11 cents. Revenue for the period of $336.8 million also failed to meet analysts' $343.9 million expectations.
For the year, the company now sees full year earnings between $2.05 and $2.25 per share, down from its previous view between $2.36 and $2.46 cents per share.
TheStreet Ratings team rates VITAMIN SHOPPE INC as a Hold with a ratings score of C+. TheStreet Ratings Team has this to say about their recommendation:
"We rate VITAMIN SHOPPE INC (VSI) a HOLD. The primary factors that have impacted our rating are mixed - some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and disappointing return on equity."
Highlights from the analysis by TheStreet Ratings Team goes as follows:
- You can view the full analysis from the report here: VSI Ratings Report
Must Read: Warren Buffett's Top 25 Stocks for 2015